Codexis

Submitted by Anonymous (not verified) on
Our partnership with Codexis sees us extending its CodeEvolver protein engineering platform. This platform helps create novel enzymes that will fuel our future innovations. We have exercised our option to license Codexis’ CDX-6114, an orally taken enzyme made to help manage phenylketonuria.
Choose partners
Image
Codexis